AU Stock MarketDetailed Quotes
ACL Australian Clinical Labs Ltd
- 3.500
- +0.030+0.86%
20min DelayMarket Closed Nov 22 16:00 AET
704.82MMarket Cap29.17P/E (Static)
3.530High3.440Low284.11KVolume3.440Open3.470Pre Close997.93KTurnover3.85552wk High0.16%Turnover Ratio201.38MShares2.08152wk Low0.12EPS TTM606.89MFloat Cap5.250Historical High29.17P/E (Static)173.40MShs Float2.081Historical Low0.12EPS LYR2.59%Amplitude0.10Dividend TTM3.97P/B1Lot Size2.86%Div YieldTTM
About Australian Clinical Labs Ltd Company
Australian Clinical Labs, or ACL, is Australia’s third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
Company Profile
SymbolACL
Company NameAustralian Clinical Labs Ltd
Founded2016
MarketASX
Employees4900
Fiscal Year Ends06-30
Address1868-1892 Dandenong Road
CityClayton
CountryAustralia
Zip Code3168
Phone+61 300453688
Share RegistryLINK MARKET SERVICES LIMITED
LEVEL 12, 680 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
1300 554 474
Company Executives
- Name
- Position
- Salary
- Melinda McGrath
- Chief Executive Officer and Director
- --
- Michael Alscher
- Chairman of the Board
- --
- Nathanial Thon
- Director
- --
- Andrew Dutton
- Independent Director
- --
- Mark Haberlin, B.Sc. ,F.C.A.
- Independent Director
- --
- Dr. Leanne Rowe, A.M.,M.D.
- Independent Director
- --
- Christine Bartlett, B.Sc. ,M.A.I.C.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data